OTC Markets OTCQB - Delayed Quote USD

Cryomass Technologies Inc. (CRYM)

0.0260
-0.0048
(-15.58%)
At close: May 9 at 3:53:06 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
37.7410
13.5520
0
0
781.4550
Cost of Revenue
0
0
0
0
744.2790
Gross Profit
37.7410
13.5520
0
0
37.1760
Operating Expense
4,654.4680
5,952.6060
10,311.8100
7,991.8270
6,572.0170
Operating Income
-4,616.7270
-5,939.0540
-10,311.8100
-7,991.8270
-6,534.8410
Net Non Operating Interest Income Expense
-599.2670
-388.9090
-147.0140
-2,189.9590
-236.9120
Other Income Expense
-3,579.8770
-6,605.9770
14.3450
47.1440
-88.6900
Pretax Income
-8,795.8710
-12,933.9400
-10,444.4790
-10,134.6420
-6,860.4430
Tax Provision
21.7880
21.7880
-21.7880
0
0
Net Income Common Stockholders
-8,817.6590
-12,955.7280
-10,422.6910
-12,859.6430
-11,815.9070
Diluted NI Available to Com Stockholders
-8,817.6590
-12,955.7280
-10,422.6910
-12,859.6430
-11,815.9070
Basic EPS
-0.03
-0.06
-0.05
-0.08
-0.12
Diluted EPS
-0.03
-0.06
-0.05
-0.08
-0.12
Basic Average Shares
219,151.8340
206,812.6160
200,884.3330
157,509.7150
99,863.0590
Diluted Average Shares
219,151.8340
206,812.6160
200,884.3330
157,509.7150
99,863.0590
Total Operating Income as Reported
-4,616.7270
-10,782.0970
-10,311.8100
-7,991.8270
-6,534.8410
Total Expenses
4,654.4680
5,952.6060
10,311.8100
7,991.8270
7,316.2960
Net Income from Continuing & Discontinued Operation
-8,817.6590
-12,955.7280
-10,422.6910
-12,859.6430
-11,815.9070
Normalized Income
-5,989.5562
-7,737.0062
-10,437.0059
-10,181.7389
-6,771.7530
Interest Expense
599.2670
388.9090
147.0140
2,189.9590
236.9120
Net Interest Income
-599.2670
-388.9090
-147.0140
-2,189.9590
-236.9120
EBIT
-8,196.6040
-12,545.0310
-10,297.4650
-7,944.6830
-6,623.5310
EBITDA
-8,075.8890
-12,215.8080
-10,135.0640
-7,901.0200
-6,623.5310
Reconciled Cost of Revenue
0
0
5.4000
0
744.2790
Reconciled Depreciation
120.7150
329.2230
157.0010
43.6630
0
Net Income from Continuing Operation Net Minority Interest
-8,817.6590
-12,955.7280
-10,422.6910
-10,134.6420
-6,860.4430
Total Unusual Items Excluding Goodwill
-3,579.8770
-6,605.9770
14.3450
47.1440
-88.6900
Total Unusual Items
-3,579.8770
-6,605.9770
14.3450
47.1440
-88.6900
Normalized EBITDA
-4,496.0120
-5,609.8310
-10,149.4090
-7,948.1640
-6,534.8410
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
-751.7742
-1,387.2552
0.0301
0.0471
0
12/31/2020 - 6/2/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PCLOF PharmaCielo Ltd.
0.0350
0.00%
 
EAPH Parallel Industries Inc.
0.0001
0.00%
 
PCLO.V PharmaCielo Ltd.
0.0500
0.00%
 
LEEEF Leef Brands Inc.
0.1320
+1.54%
 
RVVTF Revive Therapeutics Ltd.
0.0180
-1.64%
 
HASH.V SIMPLY SOLVENTLESS CONCENTRATES
0.4300
-8.51%
 
SBFM Sunshine Biopharma, Inc.
1.2500
+1.63%
 
TRUL.CN Trulieve Cannabis Corp.
6.06
-2.57%